Descending Thoracic Aortic Aneurysms: Is There a New Plan A?

The last available evidence suggests that open surgery should be the preferred treatment for intact descending thoracic aortic aneurysms. However, this study recently published in J Am Coll Cardiol, seems to have steered the wheel.

screening aneurisma aorta abdominalIn this study, open surgery was associated to increased early mortality and lower late mortality. Despite this long-term benefit, mean survival favored endovascular repair. This evidence suggests endovascular repair should be the first choice when it comes to intact thoracic aortic aneurysms.

 

This retrospective analysis used propensity score matching to compare 1235 patients undergoing surgery against 2470 patients undergoing endovascular repair between 1999 and 2010, followed up until 2014. The study looked into perioperative mortality and survival. Reinterventions were among the secondary end points.


Read also: Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference.


Periprocedural mortality was higher for the surgery group, with differences between high volume (OR: 1.97, CI 95% 1.53 to 2.61) and low volume centers (OR: 3.62 CI 95% 2.88 to 4.51), though this reversed by the end of the study. Despite early and late survival rates, mean survival after the 9-year follow-up was better with endovascular repair (p<0.001). Reintervention risk (a secondary end point) favored surgery.

 

Conclusion

Conventional surgery is associated with higher early mortality and lower late mortality compared against endovascular repair. After a 9-year follow-up, survival favors endovascular repair, which is why this should be the preferred course of action.

 

Original title: Endovascular Versus Open Repair of Intact Descending Thoracic Aortic Aneurysms.

Reference: Peter Chiu et al. J Am Coll Cardiol 2019;73:643–51.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Duration of Smoking Cessation and Risk of Amputation After Revascularization in Critical Limb Ischemia

Critical limb ischemia (CLI) is associated with high rates of amputation and mortality. Although smoking cessation improves outcomes after revascularization, the impact of the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...